Max Planck, Alnylam Attorneys Argue UMass Letter Shows Max Planck Owns Tuschl-II Inventions
August 06, 2009
Max Planck, Alnylam Attorneys Argue UMass Letter Shows Max Planck Owns Tuschl-II Inventions
The plaintiffs' counsel also provided some background on the legal dispute, including details of an early-2004 meeting between the chief executives of Alnylam and rival Sirna Therapeutics that led up to the litigation.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- In Ongoing Tuschl IP Row, USPTO OKs Planck’s Request to Pull Power of Attorney from Whitehead
September 17, 2009 / Gene Silencing News - Defendants in Tuschl-I IP Suit Cast Doubt on Claims of Pending Patent Issuance
July 16, 2009 / Gene Silencing News - Court Denies Alnylam, Max Planck’s Request to Block Tuschl-I IP Prosecution in US
September 3, 2009 / Gene Silencing News - UMass, Whitehead Fire New Salvo in Tuschl IP Suit, Claim Max Planck Meddled with Power of Attorney
August 27, 2009 / Gene Silencing News - Alnylam, Max Planck Settle Suit Over Tuschl IP
March 17, 2011 / Gene Silencing News